Circulating Tumor DNA Assays in Clinical Cancer Research

Main|Search|PHGKB




Last Posted: Jun 21, 2018

---

• Circulating Tumor DNA Assays in Clinical Cancer Research  
  MR Ossandon et al, JNCI, June 2018
• Pathology at the forefront of liquid biopsy implementation  
  PHG foundation, June 20, 2018
• Assessing the Clinical Utility & Validity of Liquid Biopsy  
  1 hour podcast from the College for American Pathologists
• Biotech Firm Takes The First Steps In Its Quest For A Blood Test For Cancer  
  M Herper, Forbes, June 2, 2018
• IASLC Statement Paper: Liquid Biopsy for Advanced Non-Small Cell Lung Cancer (NSCLC).  
  Rolfo Christian et al. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2018 Jun
• Lung cancer early detection and health disparities: the intersection of epigenetics and ethnicity.  
  Lerner Lane et al. Journal of thoracic disease 2018 Apr 10(4) 2498-2507
• Characterizing the Cancer Genome in Blood.  
  Dawson Sarah-Jane et al. Cold Spring Harbor perspectives in medicine 2018 May
• Liquid biopsy in patients with hepatocellular carcinoma: Circulating tumor cells and cell-free nucleic acids.  
  Okajima Wataru et al. World journal of gastroenterology 2017 Aug 23(31) 5650-5668
• Genomic alterations of plasma cell-free DNAs in small cell lung cancer and their clinical relevance.  
  Du Meijun et al. Lung cancer (Amsterdam, Netherlands) 2018 Jun 120113-121
• Highly sensitive detection and mutational analysis of lung cancer circulating tumor cells using integrated combined immunomagnetic beads with a droplet digital PCR chip.  
  Gao Wanlei et al. Talanta 2018 Aug 185229-236

more